Epilepsy in China: major progress in the past two decades

Area of Science:

• Neurology
• Public Health
• Global Health

Background:

• Approximately 10 million individuals in China live with epilepsy.
• A substantial treatment gap exists, influenced by healthcare system deficiencies and cultural stigma.
• The World Health Organization's Global Campaign Against Epilepsy demonstrated successful primary care interventions.

Purpose of the Study:

• To review the current landscape of epilepsy care and research in China.
• To identify progress and persistent challenges in managing epilepsy.
• To highlight the role of organizations like the China Association Against Epilepsy.

Main Methods:

• Review of existing literature and project outcomes related to epilepsy in China.
• Analysis of the availability of anti-seizure medications and non-pharmacological treatments.
• Assessment of research focus areas and expertise within the Chinese epilepsy community.

Main Results:

• Nearly 20 anti-seizure medications are accessible, alongside non-pharmacological options.
• Epidemiology and clinical research are key areas of Chinese epilepsy research.
• Despite advancements, unmet needs in epilepsy management persist.

Conclusions:

• While progress in epilepsy treatment and research is evident in China, significant public health challenges and inequalities require further attention.
• Continued efforts are needed to bridge the epilepsy treatment gap and improve care delivery nationwide.